Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

| |

LGBT+ health adviser urges Britain to make HIV-prevention drug free

South Africa Time — Tuesday, March 19, 2019

LGBT+ health adviser urges Britain to make HIV-prevention drug free
- Brady, currently medical director of the Terrence Higgins Trust (THT), one of Britain's leading HIV/AIDS charities, said he had three main priorities for ...

LEGACY - for researchers

Top stories of the last 30 days

FDA slaps clinical hold on multiple Gilead HIV trials

South Africa Time — Wednesday, June 11, 2025

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...

Nigeria : New HIV Drug May Exclude Vulnerable Populations

South Africa Time — Tuesday, June 24, 2025

The recent approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, has sparked global debate as health experts warn that its ... View article...

HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study

South Africa Time — Thursday, June 19, 2025

The experimental HIV vaccine regimen exhibited an acceptable safety profile and elicited robust immune responses in 99% of trial participants from ... View article...

HIV Prevention Has a Fantastic New Treatment

South Africa Time — Thursday, June 26, 2025

A new HIV prevention vaccine, Yezturgo Lenacapavir, is not a cure but taken twice a year, the treatment provides 99.9% protection. View article...

Weight Regain After GLP-1 Discontinuation is Less Rapid in Real World: Hamlet Gasoyan, PhD

South Africa Time — Tuesday, June 24, 2025

The prevention of HIV could monumentally shift followong the FDA approval of lenacapavir on June 19, as the twice-yearly long-acting injectable form ... View article...

Kenya's war on HIV, TB and malaria faces setback as funding drops sharply

South Africa Time — Tuesday, June 17, 2025

A nearly 40 per cent cut in government funding for Global Fund-backed health programmes is threatening to undermine Kenya's fight against HIV , TB, and ... View article...

US FDA places clinical hold on Gilead trials testing HIV pill combination

South Africa Time — Wednesday, June 11, 2025

The U.S. Food and Drug Administration has placed a clinical hold on Gilead Sciences' trials testing a combination of two of its experimental HIV ... View article...

Beetle-powered TB test aids diagnosis in HIV patients

South Africa Time — Wednesday, July 02, 2025

A credit card-sized tuberculosis test that works without electricity has shown 87 per cent accuracy in detecting TB among people living with HIV . View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2025 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

Perception of healthcare professionals about the knowledge of people living with HIV ...

South Africa Time — Thursday, July 03, 2025

Advances in HIV treatments have prolonged the lifespan of people living with HIV (PLWH), thereby increasing the risk of chronic conditions such as ... View article...

Abacavir-Based ART Regimens Linked to Higher MACE Risk in Patients With HIV

South Africa Time — Monday, July 07, 2025

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens. View article...

Key Takeaways for PrEP, HIV Treatment and Other Infectious Diseases

South Africa Time — Thursday, July 03, 2025

One of the highlights regarding HIV prevention was a study looking at lenacapavir (LEN; Gilead) once yearly for pre-exposure prophylaxis (PrEP). (LEN ... View article...

Africom Helps Regional Militaries Fight HIV/AIDS

South Africa Time — Thursday, July 03, 2025

U.S. Africa Command is making headway in helping militaries across Africa confront the HIV /AIDS epidemic through a program focused on prevention, ... View article...

A Review of Mycobacterium avium Complex Disease Treatment in Children Living With HIV/AIDS

South Africa Time — Thursday, July 03, 2025

The Guidelines for the Prevention and Treatment of Opportunistic Infections in Children with and Exposed to HIV provide treatment recommendations for ... View article...

'Unprotected sex, one time, is all it takes,' says Kiwi mum with HIV

South Africa Time — Thursday, July 03, 2025

Now, it is recommended everyone diagnosed with HIV start antiretroviral therapy (ART) immediately, regardless of their CD4 count. Susanto said how ... View article...

Are You 50 or Older? HIV Nonprofit Iris House Launched a Members-Only Club for You!

South Africa Time — Thursday, July 03, 2025

The Iris House Members Only Club in NYC combats isolation among the aging HIV community by fostering social connection. View article...

Could This Shot Prevent HIV?

South Africa Time — Tuesday, July 08, 2025

One trial showed that people without HIV infection could take antiretroviral medications to prevent getting infected. The second trial showed that ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews